Toth I - Search Results

1

Towards the development of a broadly protective group a streptococcal vaccine based on the Lipid-Core Peptide system.

Olive C, Moyle PM, Toth I. Olive C, et al. Among authors: toth i. Curr Med Chem. 2007;14(28):2976-88. doi: 10.2174/092986707782794069. Curr Med Chem. 2007. PMID: 18220734 Review.

2

Lipid, sugar and liposaccharide based delivery systems.

Wong A, Toth I. Wong A, et al. Among authors: toth i. Curr Med Chem. 2001 Jul;8(9):1123-36. doi: 10.2174/0929867013372535. Curr Med Chem. 2001. PMID: 11472244 Review.

3

Lipoamino acid-based adjuvant carrier system: enhanced immunogenicity of group a streptococcal peptide epitopes.

Horvath A, Olive C, Wong A, Clair T, Yarwood P, Good M, Toth I. Horvath A, et al. Among authors: toth i. J Med Chem. 2002 Mar 14;45(6):1387-90. doi: 10.1021/jm0110441. J Med Chem. 2002. PMID: 11882009

4

Enhancing the immunogenicity and modulating the fine epitope recognition of antisera to a helical group A streptococcal peptide vaccine candidate from the M protein using lipid-core peptide technology.

Hayman WA, Toth I, Flinn N, Scanlon M, Good MF. Hayman WA, et al. Among authors: toth i. Immunol Cell Biol. 2002 Apr;80(2):178-87. doi: 10.1046/j.1440-1711.2002.01067.x. Immunol Cell Biol. 2002. PMID: 11940119

5

A lipid core peptide construct containing a conserved region determinant of the group A streptococcal M protein elicits heterologous opsonic antibodies.

Olive C, Batzloff MR, Horváth A, Wong A, Clair T, Yarwood P, Toth I, Good MF. Olive C, et al. Among authors: toth i. Infect Immun. 2002 May;70(5):2734-8. doi: 10.1128/IAI.70.5.2734-2738.2002. Infect Immun. 2002. PMID: 11953422 Free PMC article.

6

Technological advances in antigen delivery and synthetic peptide vaccine developmental strategies.

Olive C, Toth I, Jackson D. Olive C, et al. Among authors: toth i. Mini Rev Med Chem. 2001 Nov;1(4):429-38. doi: 10.2174/1389557013406666. Mini Rev Med Chem. 2001. PMID: 12369968 Review.

7

Synthesis, structure elucidation, in vitro biological activity, toxicity, and Caco-2 cell permeability of lipophilic analogues of alpha-conotoxin MII.

Blanchfield JT, Dutton JL, Hogg RC, Gallagher OP, Craik DJ, Jones A, Adams DJ, Lewis RJ, Alewood PF, Toth I. Blanchfield JT, et al. Among authors: toth i. J Med Chem. 2003 Mar 27;46(7):1266-72. doi: 10.1021/jm020426j. J Med Chem. 2003. PMID: 12646037

8

Potential of lipid core peptide technology as a novel self-adjuvanting vaccine delivery system for multiple different synthetic peptide immunogens.

Olive C, Batzloff M, Horváth A, Clair T, Yarwood P, Toth I, Good MF. Olive C, et al. Among authors: toth i. Infect Immun. 2003 May;71(5):2373-83. doi: 10.1128/IAI.71.5.2373-2383.2003. Infect Immun. 2003. PMID: 12704107 Free PMC article.

9

Lipid and carbohydrate based adjuvant/carriers in immunology.

McGeary RP, Olive C, Toth I. McGeary RP, et al. Among authors: toth i. J Pept Sci. 2003 Jul;9(7):405-18. doi: 10.1002/psc.467. J Pept Sci. 2003. PMID: 12916638 Review.

10

Lipid core peptide technology and group A streptococcal vaccine delivery.

Olive C, Batzloff MR, Toth I. Olive C, et al. Among authors: toth i. Expert Rev Vaccines. 2004 Feb;3(1):43-58. doi: 10.1586/14760584.3.1.43. Expert Rev Vaccines. 2004. PMID: 14761243 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,006 results

Search Page

Filters